Funding Opportunity RFA-AA-18-002 from the NIH Guide for Grants and Contracts. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) seeks to continue support of the previously funded program on Translational Research in Alcoholic Hepatitis to accelerate the discovery and validation of new diagnostic and treatment options for patients with Alcoholic Hepatitis (AH). This initiative, via a set of five FOAs, aims to enhance and consolidate the existing program into AH Clinical and Translational Network, hereafter termed AH Network. This consolidated program will consist of 1) Clinical component, 2) Data Coordinating Center, 3) Translational component, and 4) Basic and pre-clinical component. Through this FOA, applications are sought to conduct investigator-initiated collaborative late phase clinical trials and observational studies in patients with AH under the U01 Collaborative Cooperative Agreements funding mechanism.

Notice NOT-GM-17-018 from the NIH Guide for Grants and Contracts

Notice NOT-AI-17-038 from the NIH Guide for Grants and Contracts

Notice NOT-RM-17-038 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AA-18-007 from the NIH Guide for Grants and Contracts. December 7, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on December 7, 2017 No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Concrete understanding of bioinformatic analysis, genomic tools, repositories, and databases. Bachelors degree in Computer Science, Biology, or related field...
From Yale New Haven Hospital - Wed, 23 Aug 2017 09:00:49 GMT - View all New Haven, CT jobs

Notice NOT-HL-17-533 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-HL-18-023 from the NIH Guide for Grants and Contracts. The purpose of this program is to recruit and retain outstanding, postdoctoral-level health professionals who have demonstrated potential and interest in pursuing careers as clinician-investigators. To address the growing need for this critical component of the research workforce, this funding opportunity seeks applications from institutional programs that can provide outstanding mentored research opportunities for Resident-Investigators and foster their ability to transition to individual career development research awards. The program will support institutions to provide support for up to 2 years of research conducted by Resident-Investigators in structured programs for clinician-investigators with defined program milestones.

Funding Opportunity PA-17-467 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages the submission of investigator-initiated research grant applications to support the secondary analysis of existing data sets with the goal of enhancing our understanding of patterns of alcohol consumption, the epidemiology and etiology, including genetics, of alcohol-related problems. Research grants for the Secondary Analyses of Existing Alcohol Research Data are intended to provide support for studies that utilize currently available data sets to increase our understanding of the incidence, prevalence and etiology of alcohol related problems and disorders in the population, as well as the risk and protective factors associated with them. Research that employs analytic techniques which demonstrate or promote methodological advances in alcohol-related epidemiologic and Genetics/Genomics research is also of interest.

Funding Opportunity PA-17-468 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages the submission of investigator-initiated research grant applications to support the secondary analysis of existing data sets with the goal of enhancing our understanding of patterns of alcohol consumption, the epidemiology and etiology, including genetics, of alcohol-related problems. Research grants for the Secondary Analyses of Existing Alcohol Research Data are intended to provide support for studies that utilize currently available data sets to increase our understanding of the incidence, prevalence and etiology of alcohol related problems and disorders in the population, as well as the risk and protective factors associated with them. Research that employs analytic techniques which demonstrate or promote methodological advances in alcohol-related epidemiologic and Genetics/Genomics research is also of interest.

Negotiable: Paramount Recruitment: Software Tester - Bioinformatics London - 12 month Fixed-Term Contract My client is seeking a talented and enthusiastic software tester to support the verification and validation of our bioinformatics software pipeline over the next 12 months. This softwa Stevenage, England

Negotiable: Paramount Recruitment: Software Engineer - Python - Central London A fantastic new position has become available for a Software Engineer to join a leading Genomics/Bioinformatics company in Central London. London, England

Notice NOT-DE-17-012 from the NIH Guide for Grants and Contracts

Notice NOT-EB-17-010 from the NIH Guide for Grants and Contracts

We utilize both animal and cellular models, and cutting edge technologies in functional genomics, bioinformatics, genetics, molecular and cell biology, and...
From Indeed - Tue, 22 Aug 2017 14:17:16 GMT - View all Oklahoma City, OK jobs

Notice NOT-CA-17-081 from the NIH Guide for Grants and Contracts

£32,000 - £40,000 depending on experience: Agenda Resource Management: A leading precision oncology services laboratory and contract research organisation are looking to recruit a Clinical Scientist! Cambridge

Competitive Salary: University of Nebraska-Lincoln: University of Nebraska-Lincoln (UNL) seeks a research associate in computational metabolomics . Lincoln, Nebraska (US)

Funding Opportunity RFA-AI-17-026 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit research applications for milestone-driven projects focused on preclinical development of lead candidate therapeutics, vaccines and related countermeasures against select NIAID Emerging Infectious Diseases/Pathogens. Applications must include a Product Development Strategy attachment and demonstrate substantive investment by at least one industrial participant.

Funding Opportunity RFA-CA-17-025 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is a part of an initiative designed to establish a Liver Cancer Consortium to advance translational research focused on early detection of liver cancer. The Consortium will consist of several Translational Research Centers (TRCs, to be supported by this U01 FOA) and a Data Management and Coordinating Center (DMCC, to be supported a companion U24 FOA, RFA-CA-17-028). The TRCs will conduct studies to improve the surveillance of liver cancer in members of high-risk populations, increase the fraction of liver cancer detected at an early stage, and better stratify patients at risk of developing liver cancer. Research to be conducted by TRCs must be based on appropriate range of biospecimens from cohorts that are focused on cirrhotic patients. A major collaborative effort of the TRCs will be the establishment of a well annotated repository of biospecimens. Biospecimens (blood, other body fluids, and, when feasible, liver tissue) may be already available and/or may be prospectively collected.